ZFX Facilitates Cell Proliferation and Imatinib Resistance in Chronic Myeloid Leukemia Cells

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Brian Druker, Moshe Talpaz, Debra Resta et al. · New England Journal of Medicine · 2001 · 5.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

Andreas Hochhaus, Sebastian Kreil, A. Corbin et al. · Leukemia · 2002 · 905 citations

Medicine, Molecular Biology, Molecular Genetics +11

Zfx Controls the Self-Renewal of Embryonic and Hematopoietic Stem Cells

José M. Galán-Caridad, Sivan Harel, Teresita L. Arenzana et al. · Cell · 2007 · 246 citations · Full text

Life Sciences, Developmental Biology, Genetics +12

Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development

Andreas Burchert, Ying Wang, Dawei Cai et al. · Leukemia · 2005 · 216 citations

Life Sciences, Cell Biology, Molecular Biology +13

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome–positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

Hagop M. Kantarjian, Jörge E. Cortes, Susan O’Brien et al. · Blood · 2002 · 161 citations · Full text

Life Sciences, Hematology, Oncology +13